Shomik Sengupta

Compliance with follow-up for patients with stage 1 testicular germ cell tumour

King Tung Cheung, Anthony Dat, Peter Wong, Caroline Dowling, Ian D Davis, Shomik Sengupta

Journal article  |  2021  |  ANZ JOURNAL OF SURGERY

BACKGROUND: This study aimed to evaluate the compliance and loss-to-follow-up (LTFU) rate in patients with stage 1 testicular germ..

Continuous Bladder Irrigation after Transurethral Resection of Non-Muscle Invasive Bladder Cancer for Prevention of Tumour Recurrence - A Systematic Review

M Li, J Toniolo, R Nandurkar, N Papa, N Lawrentschuk, ID Davis, S Sengupta

Conference Proceedings  |  2020  |  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Retroperitoneal lymph node dissection for germ cell tumour

Vy Tran, Luke Gibson, Shomik Sengupta

Journal article  |  2020  |  TRANSLATIONAL ANDROLOGY AND UROLOGY

Retroperitoneal lymph node dissection (RPLND) is an infrequently used, but important part of the management of men with metastatic..

694TiP DASL-HiCaP: Darolutamide augments standard therapy for localised very high-risk cancer of the prostate (ANZUP1801). A randomised phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation

T Niazi, S Williams, ID Davis, MR Stockler, A Martin, K Bracken, F Roncolato, M McJannett, L Horvath, S Sengupta, S Hughes, R McDermott, J Catto, P Kelly, N Vapiwala, WR Parulekar, S Morgan, RA Rendon, C Sweeney

Conference Proceedings  |  2020  |  Annals of Oncology

DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate-A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer

Tamim Niazi, Scott Williams, Ian D Davis, Martin R Stockler, Andrew James Martin, Wendy Hague, Karen Bracken, Margot Gorzeman, Felicia Roncolato, Sonia Yip, Lisa Horvath, Shomik Sengupta, Simon Hughes, Raymond S McDermott, James WF Catto, Neha Vapiwala, Wendy R Parulekar, Christopher Sweeney

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

TPS385 Background: Radiation therapy (RT), plus androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone a..

Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma

Nicola J Lawrence, Andrew Martin, Ian D Davis, Simon Troon, Shomik Sengupta, Elizabeth Hovey, Xanthi Coskinas, Richard Kaplan, Benjamin Smith, Alastair WS Ritchie, Angela Meade, Jeffrey Goh, Howard Gurney, Michelle Harrison, Kate Fife, Tim Eisen, Prunella Blinman, Martin R Stockler

Journal article  |  2020  |  KIDNEY CANCER

BACKGROUND: Little has been published regarding how doctors think and talk about prognosis and the potential benefits of adjuvant ..

Muscle invasive (MIBC) and metastatic (mBC) urothelial cancer: Modern treatment practices and clinical outcomes in Victoria

Phan Phuong, Wanda Cui, Kubra Goz, Claudia Corrente, Olivia Baenziger, Shirley Wong, Phil Dundee, Homi Zargar, Paul Anderson, Nathan Lawrentschuk, Peter Gibbs, Andrew Weickhardt, Lih-Ming Wong, Shomik Sengupta, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Fiducial markers: can the urologist do better?

Catriona Duncan, Daryl Lim Joon, Nathan Lawrentschuk, Trish Jenkins, Michal Schneider, Vincent Khoo, Michael Chao, Marita Lawlor, Rachel O'Meara, Colleen Berry, Angela Viotto, Kerryn Brown, Morikatsu Wada, Farshad Foroudi, Shomik Sengupta

Journal article  |  2019  |  WORLD JOURNAL OF UROLOGY

INTRODUCTION: Radiotherapy to the bladder has a risk of toxicity to pelvic structures, which can be reduced by using fiducial mark..

Lytic Effects of Water on Bladder Cancer Cells-Implications for Continuous Bladder Irrigation After TURBT

Ruchira Nandurkar, Pavel Sluka, Mo Li, Hady Wardan, Ian Davis, Shomik Sengupta

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells

Pavel Sluka, Carmel Pezaro, Hady Wardan, Shomik Sengupta, Ian D Davis

Journal article  |  2019  |  BJU INTERNATIONAL

OBJECTIVE: To interrogate enriched prostate cancer cells and autologous non-malignant prostate epithelial cells from men with loca..